Healthcare institutions are large, complex systems and evaluating the effects of policies or structural interventions within these systems is challenging. In many cases it is not possible to directly measure the effect of the intervention at the patient level. The… Read More »What’s wrong with a simple model?
Health economics, statistics, and health services research at the University of Warwick. Also like rock climbing and making noise on the guitar.
In a previous post I asked whether the study by Claxton et al can or should inform the cost-effectiveness threshold used by NICE. The authors argued that, “it is the expected health effects … of the average displacement within the… Read More »Identifying the effect of expenditure on health outcomes: another small comment on Claxton et al
The cost-effectiveness threshold utilised by health technology assessment agencies, such as NICE in the United Kingdom, below which new medical technologies and interventions are considered cost-effective, is frequently discussed. NICE currently use a threshold of £20,000 to £30,000 per quality… Read More »Do we really need to change the cost-effectiveness threshold?
Making headlines this morning (Thursday 20th November) has been the report by McKinsey Global Institute, an offshoot of the management consultancy McKinsey, on the global economic impact of obesity. This report estimates that $2.0 trillion is spent annually worldwide as a… Read More »How do you solve a problem like obesity?
Today sees the publication of surgeons’ death rates on the MyNHS website (see Guardian and BBC stories). The website presents full lists of surgeons by specialty alongside either blue circles with a large ‘OK’ inside, grey circles with question marks, or… Read More »Is there any use in publishing surgeons’ death rates?
There is a considerable furore surrounding the new proposal to pay GPs £55 for each dementia diagnosis. The Patients Association called it “a step too far” that would mean a “bounty on the head” of some patients (link), while the… Read More »Is payment by diagnosis for dementia a good strategy?
I stand accused. Not of a particularly heinous crime, but of something that has given me pause for thought recently. During a discussion about a piece of work involving patient outcomes, I was accused of ‘thinking like an economist’. Had… Read More »Do economists care about patients?
The use of labour market outcomes in the Value Based Pricing scheme is inconsistent with the concept of value This year, the Department of Health in the UK will begin using a new system of ‘value based pricing’ (VBP) to… Read More »The ‘value’ in value based pricing
Incentives are widely and frequently used to influence preferences among people with the aim of achieving some socially beneficial end. These incentives include fines, rewards, and taxes. From the domain of health, Pigouvian taxes on foods deemed unhealthy and pricing… Read More »Incentives and social preferences